28th Mar 2006 16:00
AstraZeneca PLC28 March 2006 Dealing by DirectorsCompanies Act 1985 Sections 324/329 We hereby inform you that on 24 March 2006 the following Directors ofAstraZeneca PLC were each granted an award under the terms of the AstraZenecaPerformance Share Plan over the Company's USD0.25 Ordinary Shares. Target number of Award price Total interest in Percentage of shares awarded per share Normal vesting shares after this shares in issue date award Name of Director D R Brennan 73,109 2975p 24 March 2009 See below See below J R Symonds 41,646 2975p 24 March 2009 108,430 0.007% J S Patterson 32,319 2975p 24 March 2009 81,390 0.005% The AstraZeneca Performance Share Plan was approved by shareholders at theCompany's AGM in 2005. Awards made under the Plan may not generally vest beforethe third anniversary of the relevant date of grant nor unless the specifiedperformance target(s) have been met at the end of the three year period which,for this award, is 1 January 2006 to 31 December 2008. The performance target that applies to this award is the Company's TotalShareholder Return ("TSR") compared to the TSR of a selected peer group of 12other pharmaceutical companies. The actual number of shares to which aparticipant may become unconditionally entitled will depend on the extent towhich the performance target(s) have been met. A summary of the Plan, includinga more detailed explanation of the performance target(s), can be found in theAstraZeneca Annual Report and Form 20-F Information 2005 which is available onthe Company's website www.astrazeneca.com. On 25 March 2005, David R Brennan, a Director of the Company, becameunconditionally entitled to a final award of 31,780 American Depositary Shares(ADSs) on the partial vesting of an original target award of 33,104 ADSs, whichwere awarded to him in March 2003 under the terms of the AstraZeneca USExecutive Performance Share Plan. Mr Brennan has ceased to have an interest inthe 1,324 ADSs of the original target award that did not vest. The closingprice of AstraZeneca ADSs on 24 March 2006 was US$51.73. One ADS equals oneOrdinary Share. In total, Mr Brennan now has an interest in 79,461 OrdinaryShares and 170,764 ADSs which together represent approximately 0.016% of thenumber of shares currently in issue. G H R MuskerCompany Secretary28 March 2006 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Astrazeneca